132 related articles for article (PubMed ID: 31231944)
1. First-in-man study of Heartech® percutaneous left ventricular partitioning device for treatment of heart failure postmyocardial infarction.
Zhu Z; Yu J; Xu K; Tang Y; Fang Y; Gu J; Gu S; Ding F; Modine T; Zhang R
Catheter Cardiovasc Interv; 2019 Nov; 94(6):845-853. PubMed ID: 31231944
[TBL] [Abstract][Full Text] [Related]
2. Heartech® left ventricular partitioning device improves left ventricular systolic function of patients with chronic heart failure post-myocardial infarction at 1-year follow-up.
Su X; Yang W; Zhu Z; Zhang R; Fang Y
Catheter Cardiovasc Interv; 2022 Jan; 99(1):50-56. PubMed ID: 33502092
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Ventricular Restoration Prevents Left Ventricular Remodeling Post Myocardial Infarction: One-Year Evaluation of the Heartech First-in-man Study.
Zhu Z; Zhu J; Yu J; Xu K; Tang Y; Fang Y; Gu S; Su X; Ding F; Ali WB; Modine T; Zhang R
J Card Fail; 2022 Apr; 28(4):604-613. PubMed ID: 35105522
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial.
Mazzaferri EL; Gradinac S; Sagic D; Otasevic P; Hasan AK; Goff TL; Sievert H; Wunderlich N; Nikolic SD; Abraham WT
Am Heart J; 2012 May; 163(5):812-820.e1. PubMed ID: 22607859
[TBL] [Abstract][Full Text] [Related]
5. Challenges in patient selection for the parachute device implantation.
Bozdag-Turan I; Bermaoui B; Paranskaya L; GökmenTuran R; D'Ancona G; Kische S; Birkemeyer R; Jovanovic B; Schuetz J; Akin I; Turan CH; Ortak J; Hauenstein K; Nienaber CA; Ince H
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E718-25. PubMed ID: 23592588
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial.
Thomas M; Nienaber CA; Ince H; Erglis A; Vukcevic V; Schäfer U; Ferreira RC; Hardt S; Verheye S; Gama Ribeiro V; Sugeng L; Tamburino C
EuroIntervention; 2015 Oct; 11(6):710-7. PubMed ID: 26499223
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study.
Costa MA; Mazzaferri EL; Sievert H; Abraham WT
Circ Heart Fail; 2014 Sep; 7(5):752-8. PubMed ID: 25037310
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
9. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.
Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT
JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study.
Yang YJ; Huo Y; Xu YW; Wang JA; Han YL; Ge JB; Zhang RY; Yan XY; Gao RL
Chin Med J (Engl); 2016 Sep; 129(17):2058-62. PubMed ID: 27569231
[TBL] [Abstract][Full Text] [Related]
11. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
[TBL] [Abstract][Full Text] [Related]
13. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L
JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646
[TBL] [Abstract][Full Text] [Related]
14. HF Etiology and cardiac contractility modulation therapy.
Davtyan K; Chugunov I; Topchyan A; Mareev Y; Mironova N; Rimskaya E; Golitsyn S; Mikhaylov E; Lebedev D; Vander M; Lyasnikova E; Sitnikova M; Minjia K; Glembo S; Sukhorukov O
BMC Cardiovasc Disord; 2024 May; 24(1):279. PubMed ID: 38811946
[TBL] [Abstract][Full Text] [Related]
15. New evidence for favourable effects on haemodynamics and ventricular performance after Parachute(®) implantation in humans.
Schmidt T; Frerker C; Thielsen T; Dotz I; Wohlmuth P; Kuck KH; Schäfer U
Eur J Heart Fail; 2014 Oct; 16(10):1112-9. PubMed ID: 25298333
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous mitral repair with the MitraClip system in patients with mild-to-moderate and severe heart failure: a single-centre experience.
Bozdag-Turan I; Paranskaya L; Birkemeyer R; Turan RG; Kische S; Akin I; Ortak J; Stoeckicht Y; Schubert J; Westphal B; Nienaber CA; Ince H
Cardiovasc Ther; 2014 Apr; 32(2):66-73. PubMed ID: 24354948
[TBL] [Abstract][Full Text] [Related]
17. Cardiac computed tomography assessment of the near term impact of percutaneous ventricular restoration therapy (parachute(®) ) on mitral valve geometry.
Tam CC; Fares A; Alaiti A; Shaikh K; Ince H; Erglis A; Bezerra HG; Abraham WT; Costa MA; Attizzani GF
Catheter Cardiovasc Interv; 2016 Aug; 88(2):E45-51. PubMed ID: 26526037
[TBL] [Abstract][Full Text] [Related]
18. Influence of experience on procedure steps, safety, and functional results in edge to edge mitral valve repair-a single center study.
Hamm K; Zacher M; Hautmann M; Gietzen F; Halbfass P; Kerber S; Diegeler A; Schieffer B; Barth S
Catheter Cardiovasc Interv; 2017 Aug; 90(2):313-320. PubMed ID: 27649934
[TBL] [Abstract][Full Text] [Related]
19. Relationship between echocardiographic parameters and exercise test duration in patients after myocardial infarction.
Wierzbowska-Drabik K; Krzemińska-Pakuła M; Plewka M; Drozdz J; Kurpesa M; Trzos E; Rechciński T; Chrzanowski L; Kasprzak JD
Cardiol J; 2009; 16(6):507-13. PubMed ID: 19950086
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
Heeger CH; Jaquet K; Thiele H; Zulkarnaen Y; Cuneo A; Haller D; Kivelitz D; Schmidt T; Krause K; Metzner A; Schneider C; Kuck KH; Bergmann MW
EuroIntervention; 2012 Oct; 8(6):732-42. PubMed ID: 23086792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
